|
|
Volumn 60, Issue 16, 2012, Pages 1580-
|
|
Absolute risk reduction due to statin use according to sex
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GENERIC DRUG;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CONFIDENCE INTERVAL;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
DRUG TOLERABILITY;
DRUG UTILIZATION;
FEMALE;
HUMAN;
LETTER;
MALE;
MEDICAL RESEARCH;
META ANALYSIS (TOPIC);
PRIMARY PREVENTION;
PRIORITY JOURNAL;
RISK REDUCTION;
SECONDARY PREVENTION;
SEX DIFFERENCE;
STATISTICAL SIGNIFICANCE;
TREATMENT OUTCOME;
UNSPECIFIED SIDE EFFECT;
CARDIOVASCULAR DISEASES;
FEMALE;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
MALE;
|
|
EID: 84867351873
PISSN: 07351097
EISSN: 15583597
Source Type: Journal
DOI: 10.1016/j.jacc.2012.03.081 Document Type: Letter |
|
Times cited : (5)
|
|
References (2)
|
